Oral FLT3/BTK inhibitor CG-806 expands development beyond B-cell malignancies to the treatment of AMLPhase 1a/b study in B-cell malignancies continues […]
WATERLOO, Ontario, June 29, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses […]